These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16624786)

  • 1. Application of new WAIS-III/WMS-III discrepancy scores for evaluating memory functioning: relationship between intellectual and memory ability.
    Lange RT; Chelune GJ
    J Clin Exp Neuropsychol; 2006 May; 28(4):592-604. PubMed ID: 16624786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of WAIS-III General Ability Index Minus WMS-III memory discrepancy scores.
    Lange RT; Chelune GJ; Tulsky DS
    Clin Neuropsychol; 2006 Sep; 20(3):382-95. PubMed ID: 16895854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the relationship between WAIS-III premorbid intellectual functioning and WMS-III memory ability to evaluate memory impairment.
    Lange RT; Chelune GJ
    Appl Neuropsychol; 2007; 14(3):171-7. PubMed ID: 17848127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of the Faces subtest by Visual Reproductions within Wechsler Memory Scale-Third Edition (WMS-III) visual memory indexes: implications for discrepancy analysis.
    Hawkins KA; Tulsky DS
    J Clin Exp Neuropsychol; 2004 Jun; 26(4):498-510. PubMed ID: 15512937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the WAIS-III general ability index estimate (GAI-E).
    Lange RT; Schoenberg MR; Chelune GJ; Scott JG; Adams RL
    Clin Neuropsychol; 2005 Feb; 19(1):73-86. PubMed ID: 15814479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAIS-III FSIQ and GAI in ability-memory discrepancy analysis.
    Glass LA; Bartels JM; Ryan JJ
    Appl Neuropsychol; 2009; 16(1):19-22. PubMed ID: 19205944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the WAIS-III Estimate of Premorbid Ability for Canadians (EPAC).
    Lange RT; Schoenberg MR; Saklofske DH; Woodward TS; Brickell TA
    J Clin Exp Neuropsychol; 2006 Jul; 28(5):773-89. PubMed ID: 16723324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed working memory on the WMS-III as a marker for poor effort.
    Lange RT; Iverson GL; Sullivan K; Anderson D
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):294-305. PubMed ID: 16618621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory deficits in patients with schizophrenia: preliminary data from the Wechsler Memory Scale-Third Edition support earlier findings.
    Hawkins KA
    J Psychiatry Neurosci; 1999 Sep; 24(4):341-7. PubMed ID: 10516802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical validation of the General Ability Index--Estimate (GAI-E): estimating premorbid GAI.
    Schoenberg MR; Lange RT; Iverson GL; Chelune GJ; Scott JG; Adams RL
    Clin Neuropsychol; 2006 Sep; 20(3):365-81. PubMed ID: 16895853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between measures of psychopathology, intelligence, and memory among adults seen for psychoeducational assessment.
    Morasco BJ; Gfeller JD; Chibnall JT
    Arch Clin Neuropsychol; 2006 May; 21(4):297-301. PubMed ID: 16777372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of WAIS-III/WMS-III demographically corrected factor scores in neuropsychological assessment.
    Taylor MJ; Heaton RK
    J Int Neuropsychol Soc; 2001 Nov; 7(7):867-74. PubMed ID: 11771630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parsing the recognition memory components of the WMS-III face memory subtest: normative data and clinical findings in dementia groups.
    Holdnack JA; Delis DC
    J Clin Exp Neuropsychol; 2004 Jun; 26(4):459-83. PubMed ID: 15512935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new Delayed Memory Index for the WMS-III.
    Tulsky DS; Chelune GJ; Price LR
    J Clin Exp Neuropsychol; 2004 Jun; 26(4):563-76. PubMed ID: 15512943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WMS-III findings in litigants following moderate to extremely severe brain trauma.
    Langeluddecke PM; Lucas SK
    J Clin Exp Neuropsychol; 2005 Jul; 27(5):576-90. PubMed ID: 16019634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of IQ stratification on WAIS-III/WMS-III FSIQ-general memory index discrepancy base-rates in the standardization sample.
    Hawkins KA; Tulsky DS
    J Int Neuropsychol Soc; 2001 Nov; 7(7):875-80. PubMed ID: 11771631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new look at the WMS-III: new research to guide clinical practice.
    Tulsky DS
    J Clin Exp Neuropsychol; 2004 Jun; 26(4):453-8. PubMed ID: 15512934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-norming the WAIS-III and WMS-III: Is there a test-order effect on IQ and memory scores?
    Zhu J; Tulsky DS
    Clin Neuropsychol; 2000 Nov; 14(4):461-7. PubMed ID: 11262715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of demographic norms for four new WAIS-III/WMS-III indexes.
    Lange RT; Chelune GJ; Taylor MJ; Woodward TS; Heaton RK
    Psychol Assess; 2006 Jun; 18(2):174-81. PubMed ID: 16768593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digit Symbol-Incidental Learning in the WAIS-III: construct validity and clinical significance.
    Joy S; Kaplan E; Fein D
    Clin Neuropsychol; 2003 May; 17(2):182-94. PubMed ID: 13680425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.